• 1Regor’s discovery team published their Structural Biology work on the human glucagon-like peptide-1 receptor (GLP1R) in June 18, 2021 issue of Nature Communications

    Regor’s discovery team under Dr. Wenge Zhong’s leadership, in collaboration with Professor Eric Xu at the Shanghai Institute of Materia Medica and other academic teams at Fudan University and Zhejiang University, published Structural Biology work on the human glucagon-like peptide-1 receptor (GLP1R). Using cryo-electron microscopy, the teams were able to solve three complex structures, providing structural basis and deep molecular insights on the ago-allosteric modulation of the GLP1 receptor.

    The article can be accessed here



  • 2Marjorie Zettler, Director of Clinical Science, was on the cover of May 25, 2021 issue of HemOnc Today magazine

    HemOnc Today spoke with Marjorie Zettler, PhD, MPH, and other experts about FDA’s accelerated approval program, and their recent decision to re-evaluate the evidence for several oncology drugs after confirmatory trials failed.

    FDA’s accelerated approval program: Reevaluating the need for speed (healio.com)



245 Main Street, Second Floor, Cambridge, MA 02142, USA
1206 Zhangjiang Rd, Building C, Pudong New District, Shanghai 201210, China